The effect of serum progesterone on third day after intrauterine insemination (IUI) on pregnancy outcomes in two different methods of progesterone administratio
Phase 3
- Conditions
- Infertility.
- Registration Number
- IRCT20200905048630N3
- Lead Sponsor
- Bandare-abbas University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 140
Inclusion Criteria
IUI cycles
Patients with normal uterine cavity
Exclusion Criteria
Patients with uterine abnormalities such as myoma, anatomical problems, polyp, salpangitis
Patients with a history of recurrent miscarriage
Age over 37 years old
Patients with grade 3 or 4 endometriosis
BMI over 30 kg/m2
Previous ectopic pregnancy
Usage two type of progesterone for luteal phase support
Endometrial thickness lower than 7mm on trigger day
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical pregnancy. Timepoint: 14 days after IUI. Method of measurement: Beta serum level evaluation.;Biochemical pregnancy. Timepoint: 8 weeks after IUI. Method of measurement: Sonography.
- Secondary Outcome Measures
Name Time Method